rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1997-6-2
|
pubmed:abstractText |
In heart transplant recipients methotrexate has been shown to reverse recurrent/persistent acute rejection refractory to intensified conventional immunosuppression. This study sought to determine whether methotrexate produces a sustained decline of heart allograft rejection rates and renders rejection rates of patients with a history of recurrent/persistent rejection similar to those of heart transplant recipients without such history.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1053-2498
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
169-78
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9059928-Acute Disease,
pubmed-meshheading:9059928-Adolescent,
pubmed-meshheading:9059928-Adult,
pubmed-meshheading:9059928-Aged,
pubmed-meshheading:9059928-Child,
pubmed-meshheading:9059928-Coronary Angiography,
pubmed-meshheading:9059928-Coronary Disease,
pubmed-meshheading:9059928-Female,
pubmed-meshheading:9059928-Follow-Up Studies,
pubmed-meshheading:9059928-Graft Rejection,
pubmed-meshheading:9059928-Heart Transplantation,
pubmed-meshheading:9059928-Humans,
pubmed-meshheading:9059928-Immunosuppressive Agents,
pubmed-meshheading:9059928-Male,
pubmed-meshheading:9059928-Methotrexate,
pubmed-meshheading:9059928-Middle Aged,
pubmed-meshheading:9059928-Recurrence,
pubmed-meshheading:9059928-Retrospective Studies,
pubmed-meshheading:9059928-Survival Rate
|
pubmed:year |
1997
|
pubmed:articleTitle |
Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
|
pubmed:affiliation |
Rush-Presbyterian-St. Luke's Heart Failure and Cardiac Transplant Program, Chicago, IL 60612, USA.
|
pubmed:publicationType |
Journal Article
|